BPC-157 is one of the most extensively researched synthetic peptides in current scientific literature. Derived from a protein found in gastric juice, this 15 amino acid compound has attracted significant laboratory interest due to its remarkable stability and the breadth of biological systems it appears to interact with in research models.
What Is BPC-157?
BPC-157 stands for Body Protection Compound 157. It is a pentadecapeptide — a chain of exactly 15 amino acids — that was isolated and synthesised from a protein sequence naturally present in human gastric juice. The full amino acid sequence is Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val.
Unlike many synthetic peptides which degrade rapidly when exposed to biological environments, BPC-157 demonstrates remarkable stability in both gastric acid and plasma, making it a particularly interesting subject for laboratory investigation.
BPC-157 Synthesis and Purity
BPC-157 is produced via Solid Phase Peptide Synthesis (SPPS). At 15 amino acids it sits in the mid-range of complexity for synthetic peptides — longer than simple tripeptides like GHK-Cu but significantly shorter than complex compounds like Retatrutide.
This moderate chain length means high purity synthesis is reliably achievable. Quality manufacturers routinely produce BPC-157 at 98-99%+ purity as confirmed by HPLC analysis. The compound typically presents as a white to off-white lyophilised powder with a molecular weight of approximately 1419 Da.
Areas of Scientific Investigation
BPC-157 has been the subject of numerous peer reviewed studies, primarily conducted in rodent models. Research has examined its interaction with several biological systems.
Gastrointestinal research has explored BPC-157 extensively given its origin from gastric proteins. Multiple studies have examined its effects on gastrointestinal tissue in laboratory and animal models, making it one of the most studied peptides in this specific research area.
Tendon and ligament research represents another significant area of scientific literature. Studies have examined BPC-157 in the context of connective tissue biology, with particular interest in its interaction with growth factor signalling pathways.
Neurological research has investigated BPC-157 in models examining dopaminergic and serotonergic systems, as well as studies relating to stress responses in animal models.
Angiogenesis research has looked at BPC-157 in the context of blood vessel formation, with studies suggesting interaction with VEGF pathways in laboratory settings.
BPC-157 Stability and Storage
One of BPC-157’s notable characteristics is its exceptional stability compared to many research peptides. In its lyophilised form it maintains integrity well under proper storage conditions.
For laboratory storage, lyophilised BPC-157 powder should be kept at 2-8°C for short term use and -20°C for long term storage. It should be protected from light and moisture. Once reconstituted it should be refrigerated and used within an appropriate research timeframe.
Reconstitution for Laboratory Use
BPC-157 is supplied as a lyophilised powder that requires reconstitution with bacteriostatic water before use in liquid based assays. Standard laboratory practice involves adding bacteriostatic water slowly to the vial, allowing it to dissolve without agitation or shaking which can denature the peptide structure.
The concentration required will depend entirely on the specific research protocol being followed. Researchers should consult relevant literature and their own institutional guidelines when determining appropriate concentrations for their specific in vitro applications.
Verifying BPC-157 Quality
Given the volume of BPC-157 available from various international sources, quality verification is essential for serious research applications. A reliable Certificate of Analysis should include HPLC chromatogram data showing the purity percentage, mass spectrometry data confirming the molecular weight matches the expected 1419 Da, and batch specific information linking the certificate to the exact product supplied.
At Pureline Biolabs our BPC-157 is independently tested by Janoshik Analytical with a minimum specification of 99% purity. Every vial carries a unique QR code linking to the live, publicly accessible certificate for that specific batch.
Legal Status in the UK
BPC-157 is not a licensed medicine in the United Kingdom and is not approved by the MHRA for human or veterinary use. It is legally available for purchase and possession for genuine laboratory research purposes. Suppliers are required to sell it strictly under research use only conditions with no therapeutic claims.
Pureline Biolabs supplies BPC-157 exclusively for in vitro laboratory research purposes in compliance with UK regulations.
Important Disclaimer
All products supplied by Pureline Biolabs Ltd are intended solely for in vitro laboratory research purposes. They are not medicines, not approved for human or veterinary use, and not for human consumption. Researchers are responsible for ensuring compliance with all applicable regulations in their jurisdiction.